Burkitt Lymphoma

Symptoms, Doctors, Treatments, Research & More

Condition 101

What is the definition of Burkitt Lymphoma?

Burkitt lymphoma (BL) is a very fast growing form of non-Hodgkin lymphoma.

What are the alternative names for Burkitt Lymphoma?

B-cell lymphoma; High-grade B-cell lymphoma; Small noncleaved cell lymphoma

What are the causes for Burkitt Lymphoma?

BL was first discovered in children in certain parts of Africa. It also occurs in the United States.

The African type of BL is closely associated with the Epstein-Barr virus (EBV), the main cause of infectious mononucleosis. The North American form of BL is not linked to EBV.

People with HIV/AIDS have an increased risk for this condition. BL is most often seen in males.

What are the symptoms for Burkitt Lymphoma?

BL may first be noticed as a swelling of the lymph nodes (glands) in the head and neck. These swollen lymph nodes are often painless, but can grow very rapidly.

In the types commonly seen in the United States, the cancer often starts in the belly area (abdomen). The disease can also start in the ovaries, testes, brain, kidneys, liver, and spinal fluid.

Other general symptoms may include:

  • Fever
  • Night sweats
  • Unexplained weight loss

What are the current treatments for Burkitt Lymphoma?

Chemotherapy is used to treat this type of cancer. If the cancer does not respond to chemotherapy alone, a bone marrow transplant may be done.

What is the outlook (prognosis) for Burkitt Lymphoma?

More than one half of people with BL can be cured with intensive chemotherapy. The cure rate may be lower if the cancer spreads to the bone marrow or spinal fluid. The outlook is poor if the cancer comes back after a remission or does not go into remission as a result of the first cycle of chemotherapy.

What are the possible complications for Burkitt Lymphoma?

Possible complications of BL include:

  • Complications of treatment
  • Spread of the cancer

When should I contact a medical professional for Burkitt Lymphoma?

Call your provider if you have symptoms of BL.



Lewis R, Plowman PN, Shamash J. Malignant disease. In: Feather A, Randall D, Waterhouse M, eds. Kumar and Clarke's Clinical Medicine. 10th ed. Philadelphia, PA: Elsevier; 2021:chap 6.

National Cancer Institute website. Adult non-Hodgkin lymphoma treatment (PDQ) - health professional version. Updated June 26, 2020. Accessed August 5, 2020.

Said JW. Immunodeficiency-related lymphoproliferative disorders. In: Jaffe ES, Arber DA, Campo E, Harris NL, Quintanilla-Martinez L, eds. Hematopathology. 3rd ed. Philadelphia, PA: Elsevier; 2018:chap 10.

Top Global Doctors

Reiner Siebert
Ulm, BW, DE
Koichi I. Ohshima
Kurume, 40, JP
Lorenzo Leoncini
Siena, 52, IT
German K. Ott
Stuttgart, BW, DE
Martin D. Ogwang
Gulu, N, UG

Latest Research

Latest Advance
  • Condition: Burkitt Leukemia
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Rituximab
  • Number of Patients: 11
  • Published —
This study tested the safety and efficacy of using rituximab to treat patients with Burkitt leukemia.
Latest Advance
  • Condition: Burkitt Lymphoma
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: LMB 89± Rituximab
  • Number of Patients: 43
  • Published —
The study researched the outcomes of treatment with LMB 89± rituximab for Burkitt lymphoma.

Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 60
  • Start Date: November 14, 2020
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative Regimen
Clinical Trial
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 36
  • Start Date: September 11, 2020
A Phase 1 Clinical Trial of Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma